ZimVie (NASDAQ:ZIMV) Lowered to Buy Rating by Wall Street Zen

ZimVie (NASDAQ:ZIMV - Get Free Report) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a note issued to investors on Friday.

A number of other research analysts have also commented on ZIMV. UBS Group decreased their price target on shares of ZimVie from $16.00 to $10.00 and set a "neutral" rating on the stock in a research note on Thursday, May 15th. B. Riley assumed coverage on shares of ZimVie in a research note on Thursday, April 10th. They issued a "buy" rating and a $16.00 price target on the stock. Finally, Needham & Company LLC reiterated a "hold" rating on shares of ZimVie in a research note on Wednesday, April 9th.

ZimVie Stock Down 2.5%

ZimVie stock opened at $8.44 on Friday. The firm has a market capitalization of $235.05 million, a PE ratio of -11.89 and a beta of 2.07. The company's 50-day moving average is $9.05 and its 200-day moving average is $10.94. ZimVie has a fifty-two week low of $8.15 and a fifty-two week high of $22.18. The company has a debt-to-equity ratio of 0.58, a current ratio of 2.14 and a quick ratio of 1.48.

ZimVie (NASDAQ:ZIMV - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.06. The company had revenue of $112.00 million for the quarter, compared to analyst estimates of $113.10 million. ZimVie had a negative net margin of 4.40% and a positive return on equity of 5.53%. Sell-side analysts anticipate that ZimVie will post 0.6 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of ZIMV. Bank of New York Mellon Corp boosted its holdings in ZimVie by 0.9% in the 4th quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company's stock valued at $1,404,000 after purchasing an additional 943 shares during the period. JPMorgan Chase & Co. boosted its holdings in ZimVie by 18.7% in the 4th quarter. JPMorgan Chase & Co. now owns 217,773 shares of the company's stock valued at $3,038,000 after purchasing an additional 34,354 shares during the period. LPL Financial LLC bought a new stake in ZimVie in the 4th quarter valued at about $993,000. BNP Paribas Financial Markets bought a new stake in ZimVie in the 4th quarter valued at about $416,000. Finally, Fox Run Management L.L.C. bought a new stake in ZimVie in the 4th quarter valued at about $463,000. Institutional investors and hedge funds own 95.63% of the company's stock.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.